Referred to the Committee on Small Business, and in addition to the Committees on Science, Space, and Technology, and the Judiciary, for a period to be subsequently determined by…
The bill amends the Small Business Act to strengthen commercialization support in SBIR and STTR programs. It requires peer review to include commercialization likelihood and commercialization reviewers, expands agency phase-flexibility authority with funding limits, creates designated Technology Commercialization Officials, increases and clarifies technical and business assistance (including hiring staff), requires I‑Corps participation options, mandates an annual commercialization impact assessment, and directs SBA to partner with the USPTO for prioritized patent examination and outreach.
Liberal emphasizes equity and public‑interest safeguards; conservatives see government overreach.
Relative to its intended legislative type, this bill provides a structured and reasonably detailed set of statutory changes to enhance commercialization in SBIR/STTR programs, with concrete mechanisms (reviewer standards, funding caps, technical assistance amounts, designated officials, and defined metrics) and defined accountability pathways.
The bill amends the Small Business Act to strengthen commercialization support in SBIR and STTR programs.
It requires peer review to include commercialization likelihood and commercialization reviewers, expands agency phase-flexibility authority with funding limits, creates designated Technology Commercialization Officials, increases and clarifies technical and business assistance (including hiring staff), requires I‑Corps participation options, mandates an annual commercialization impact assessment, and directs SBA to partner with the USPTO for prioritized patent examination and outreach.
Administrative SBIR/STTR tweaks typically face low ideological resistance and can pass if prioritized, but multi-committee referral and implementation details add friction.
Relative to its intended legislative type, this bill provides a structured and reasonably detailed set of statutory changes to enhance commercialization in SBIR/STTR programs, with concrete mechanisms (reviewer standards, funding caps, technical assistance amounts, designated officials, and defined metrics) and defined accountability pathways.
Liberal emphasizes equity and public‑interest safeguards; conservatives see government overreach.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes equity and public‑interest safeguards; conservatives see government overreach.
Generally supportive because the bill strengthens support for small innovators and helps move federally funded research toward public-facing products.
Will welcome increased assistance, patent support, and reporting, while wanting safeguards for equitable access and protection of public-interest research.
Practical and cautiously favorable: the bill makes concrete, administrable changes to improve commercialization pathways.
Supports clearer metrics and technical assistance but wants cost estimates, performance evaluation, and careful implementation to avoid waste.
Skeptical: supports pro-small-business commercialization but concerned about added federal mandates, reporting, and potential taxpayer support for private commercialization.
Appreciates patent assistance and DOD flexibility, but views new officials and expanded TA as government overreach.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Administrative SBIR/STTR tweaks typically face low ideological resistance and can pass if prioritized, but multi-committee referral and implementation details add friction.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes equity and public‑interest safeguards; conservatives see government overreach.
Administrative SBIR/STTR tweaks typically face low ideological resistance and can pass if prioritized, but multi-committee referral and imp…
Relative to its intended legislative type, this bill provides a structured and reasonably detailed set of statutory changes to enhance commercialization in SBIR/STTR programs, with concrete mechanisms (reviewer standard…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.